MLchartDataset catalogue

Lorbrena

Term · Oncology and biomedicine · MLC-T-ONC-004933

A drug used to treat adults with non-small cell lung cancer that has spread to other parts of the body and is ALK positive. It is also being studied in the treatment of other types of cancer. Lorbrena blocks certain proteins made by the ALK gene. Blocking these proteins may stop the growth and spread of cancer cells. Lorbrena is a type of tyrosine kinase inhibitor. Also called lorlatinib.

Table 1. Record
IdentifierMLC-T-ONC-004933
FieldOncology and biomedicine
Synonymslorlatinib
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-004933",
  "term": "Lorbrena",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat adults with non-small cell lung cancer that has spread to other parts of the body and is ALK positive. It is also being studied in the treatment of other types of cancer. Lorbrena blocks certain proteins made by the ALK gene. Blocking these proteins may stop the growth and spread of cancer cells. Lorbrena is a type of tyrosine kinase inhibitor. Also called lorlatinib.",
  "synonyms": [
    "lorlatinib"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/lorbrena/"
}

Record 10,308 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.